Kobbe G - Search Results

1

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.

Rautenberg C, Stölzel F, Röllig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, Verbeek M, Unglaub JM, Thol F, Krause SW, Hänel M, Neuerburg C, Vucinic V, Jehn CF, Severmann J, Wass M, Fransecky L, Chemnitz J, Holtick U, Schäfer-Eckart K, Schröder J, Kraus S, Krüger W, Kaiser U, Scholl S, Koch K, Henning L, Kobbe G, Haas R, Alakel N, Röhnert MA, Sockel K, Hanoun M, Platzbecker U, Holderried TAW, Morgner A, Heuser M, Sauer T, Götze KS, Wagner-Drouet E, Döhner K, Döhner H, Schliemann C, Schetelig J, Bornhäuser M, Germing U, Schroeder T, Middeke JM. Rautenberg C, et al. Among authors: kobbe g. Blood Cancer J. 2021 Oct 4;11(10):164. doi: 10.1038/s41408-021-00558-5. Blood Cancer J. 2021. PMID: 34608129 Free PMC article. Clinical Trial.

2

Early occurrence of an adenocarcinoma after allogeneic bone marrow transplantation in a patient with AML.

Germing U, Kobbe G, Sohngen D, Motherby H, Braunstein S, Heyll A, Aul C. Germing U, et al. Among authors: kobbe g. Oncol Rep. 1999 Jul-Aug;6(4):855-7. doi: 10.3892/or.6.4.855. Oncol Rep. 1999. PMID: 10373670

3

Massive extramedullary disease progression in a patient with stable multiple myeloma during G-CSF priming for peripheral blood progenitor mobilization.

Kobbe G, Germing U, Soehngen D, Aul C, Heyll A. Kobbe G, et al. Oncol Rep. 1999 Sep-Oct;6(5):1151-2. doi: 10.3892/or.6.5.1151. Oncol Rep. 1999. PMID: 10425318

4

Long-term remission after intensive chemotherapy in advanced myelodysplastic syndromes is generally associated with restoration of polyclonal haemopoiesis.

Aivado M, Rong A, Germing U, Gattermann N, Kobbe G, Rieth C, Haas R, Aul C. Aivado M, et al. Among authors: kobbe g. Br J Haematol. 2000 Sep;110(4):884-6. doi: 10.1046/j.1365-2141.2000.02302.x. Br J Haematol. 2000. PMID: 11054075 Free article.

5

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.

Kobbe G, Schneider P, Aivado M, Zohren F, Schubert D, Fenk R, Neumann F, Kronenwett R, Pape H, Rong A, Royer-Pokora B, Hildebrandt B, Germing U, Gattermann N, Heyll A, Haas R. Kobbe G, et al. Exp Hematol. 2002 Nov;30(11):1346-53. doi: 10.1016/s0301-472x(02)00923-2. Exp Hematol. 2002. PMID: 12423689 Free article.

6

Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation.

Kobbe G, Germing U, Aivado M, Zohren F, Schubert D, Strupp C, Pape H, Tenderich G, Körfer R, Storb R, Haas R, Schneider P. Kobbe G, et al. Transplantation. 2002 Oct 27;74(8):1198-200. doi: 10.1097/00007890-200210270-00027. Transplantation. 2002. PMID: 12438973

7

Primary human CD34+ hematopoietic stem and progenitor cells express functionally active receptors of neuromediators.

Steidl U, Bork S, Schaub S, Selbach O, Seres J, Aivado M, Schroeder T, Rohr UP, Fenk R, Kliszewski S, Maercker C, Neubert P, Bornstein SR, Haas HL, Kobbe G, Tenen DG, Haas R, Kronenwett R. Steidl U, et al. Among authors: kobbe g. Blood. 2004 Jul 1;104(1):81-8. doi: 10.1182/blood-2004-01-0373. Epub 2004 Mar 11. Blood. 2004. PMID: 15016651 Free article.

8

Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.

Kobbe G, Fenk R, Neumann F, Bernhardt A, Steidl U, Kondakci M, Graef T, Aivado M, Vaupel M, Huenerlituerkoglu AN, Kronenwett R, Pape H, Hildebrand B, Germing U, Haas R. Kobbe G, et al. Cytotherapy. 2004;6(6):533-42. doi: 10.1080/14653240410005375. Cytotherapy. 2004. PMID: 15764020

9

Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.

Neumann F, Graef T, Tapprich C, Vaupel M, Steidl U, Germing U, Fenk R, Hinke A, Haas R, Kobbe G. Neumann F, et al. Among authors: kobbe g. Bone Marrow Transplant. 2005 Jun;35(11):1089-93. doi: 10.1038/sj.bmt.1704956. Bone Marrow Transplant. 2005. PMID: 15821769

10

The ratio between CD4+ and CD8+ cells in the peripheral blood of patients with hematological malignancies is not altered by thalidomide.

Strupp C, Germing U, Aivado M, Kündgen A, Fenk R, Hünerlitürkoglu A, Kobbe G, Haas R, Gattermann N. Strupp C, et al. Among authors: kobbe g. Leuk Lymphoma. 2005 Jul;46(7):999-1006. doi: 10.1080/10428190500078300. Leuk Lymphoma. 2005. PMID: 16019550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page